Rosuvastatin Calcium Tablet, Film Coated
Product Images NDC 51655-062

5 FDA label images from Northwind Health Company, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Rosuvastatin Calcium (NDC 51655-062). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Rosuvastatin Structure)

Structure (Rosuvastatin Structure)
Chemical structure diagram of rosuvastatin calcium, showing the molecular arrangement of atoms and bonds including fluorophenyl, sulfonyl, hydroxyl, and carboxylate groups with calcium ion indicated.*
FDA Label Image

Rosuvastatin-fig-01 (Rosuvastatin Fig 01)

Rosuvastatin-fig-01 (Rosuvastatin Fig 01)
A Kaplan-Meier plot showing cumulative incidence percentage over 5 years comparing Rosuvastatin (solid line) with Placebo (dotted line). The graph includes hazard ratio (HR 0.56; 95% CI 0.46-0.69) and a p-value less than 0.001. Below the x-axis is a risk table indicating participant numbers at various time points for both groups.*
FDA Label Image

Rosuvastatin-fig-02 (Rosuvastatin Fig 02)

Rosuvastatin-fig-02 (Rosuvastatin Fig 02)
A data table presenting the number of events, hazard ratios (HR with 95% CI), and P values comparing Rosuvastatin Calcium 20 mg to placebo 20 mg across various cardiovascular endpoints including primary end point (MCE), cardiovascular death, nonfatal stroke, nonfatal myocardial infarction, hospitalized unstable angina, and arterial revascularization. A forest plot illustrates hazard ratios graphically.*
FDA Label Image

Rosuvastatin-fig-03 (Rosuvastatin Fig 03)

Rosuvastatin-fig-03 (Rosuvastatin Fig 03)
Box plot chart comparing percent change from baseline in LDL-C for different doses of four statins: Rosuvastatin, Atorvastatin, Simvastatin, and Pravastatin. The x-axis displays doses in milligrams, and the y-axis shows percent change, ranging from 0 to -75. Each drug's dose-response is visualized with box plots showing variability and median effects on LDL-C reduction.*
FDA Label Image

Label (51655 062 52 Rev A 09 22 Nhc)

Label (51655 062 52   Rev A 09 22 Nhc)
Label for Rosuvastatin Calcium tablets USP 10 mg by Northwind Health Company, LLC. The label indicates a 30-tablet package for oral use, prescription only. Storage instructions specify 20°-25°C controlled room temperature, with warnings to keep out of reach of children and protect from moisture. The label includes NDC 51655-062-52 and packaging details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.